Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lanreotide Autogel in Acromegaly
NCT00210457Phase 3Completed
- Sponsor
- Ipsen
- Start
- Sep 2000
- Primary completion
- Jul 2002
- Modality
- Peptides
- Countries
- 2
01
Overview
A Phase 3 trial of lanreotide in acromegaly, sponsored by Ipsen. Started Sep 2000; status: completed.
02
Drugs
lanreotide
03
Conditions
acromegaly
Beyond the preview
Go deeper on NCT00210457.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00210457.